2020
DOI: 10.1002/jcp.29788
|View full text |Cite
|
Sign up to set email alerts
|

Rapid human‐derived iPSC osteogenesis combined with three‐dimensionally printed Ti6Al4V scaffolds for the repair of bone defects

Abstract: Human‐induced pluripotent stem cells (iPSCs) are an alternative source of mesenchymal stem cells used for bone regeneration. However, the current osteogenically induced methods for iPSCs are slow and complex. We have used retinoic acid (RA) to induce osteogenic iPSCs within 10 days and assess whether a rapid differentiation could improve the osteogenic potential of the three‐dimensionally printed Ti6Al4V (3DTi) scaffolds. First, the osteogenic differentiation of iPSCs was induced with RA, and the osteogenic po… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 26 publications
0
9
0
Order By: Relevance
“…Despite its low degradation rate, the PCL matrix is limited in terms of cellular adhesion and osteogenic differentiation, several authors [ 32 , 35 , 49 , 50 , 53 , 62 ] have suggested combining it with different polymers [ 37 ] and bioactive molecules such as rBMP-2, that promote proliferation and differentiation of mesenchymal stem cells into osteoblasts resulting in bone formation. Nonetheless, a recently published umbrella review regarding the efficiency of current approaches in regeneration of bone defects in non-syndromic patients with cleft palate concluded that rBMP2 seems to provide results similar to the iliac crest bone graft in terms of bone volume and vertical dimension [ 121 ]. Another limitation of the PCL matrix is its low hydrophilia [ 52 ], which can be amended when the matrix is combined with a hydrophilic material such as β -TCP [ 35 , 66 , 77 ] or polydopamine [ 37 ].…”
Section: Discussionmentioning
confidence: 99%
“…Despite its low degradation rate, the PCL matrix is limited in terms of cellular adhesion and osteogenic differentiation, several authors [ 32 , 35 , 49 , 50 , 53 , 62 ] have suggested combining it with different polymers [ 37 ] and bioactive molecules such as rBMP-2, that promote proliferation and differentiation of mesenchymal stem cells into osteoblasts resulting in bone formation. Nonetheless, a recently published umbrella review regarding the efficiency of current approaches in regeneration of bone defects in non-syndromic patients with cleft palate concluded that rBMP2 seems to provide results similar to the iliac crest bone graft in terms of bone volume and vertical dimension [ 121 ]. Another limitation of the PCL matrix is its low hydrophilia [ 52 ], which can be amended when the matrix is combined with a hydrophilic material such as β -TCP [ 35 , 66 , 77 ] or polydopamine [ 37 ].…”
Section: Discussionmentioning
confidence: 99%
“…Improving the differentiation process of pluripotent stem cells through understanding the signaling cues that control and contribute to the differentiation process to the desired cell type, in addition to the correct choice of the transplantation scaffold, can yield a successful nearby clinical therapy for a wide variety of tissue and organ defects [ 40 , 41 , 42 ].…”
Section: Discussionmentioning
confidence: 99%
“…They found that this process could be improved using 3Dprinted Ti6Al4V scaffolds. [140] In vivo, experiments have confirmed the ability of iPSCs to form bones. Duan et al combined enamel matrix derivatives (EMDs) with human iPSCs for periodontal tissue regeneration in nude mice.…”
Section: Attempts To Use Ipscs For Anti-osteoporosismentioning
confidence: 92%
“…They found that this process could be improved using 3D‐printed Ti6Al4V scaffolds. [ 140 ] In vivo, experiments have confirmed the ability of iPSCs to form bones. Duan et al.…”
Section: Attempts To Use Cell‐based Therapies In the Treatment Of Dmdsmentioning
confidence: 99%